Literature DB >> 16968318

Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.

N Humpel1, S C Jones.   

Abstract

The aim of this study was to gain a greater understanding of complementary and alternative medicine (CAM) use among cancer patients and survivors. Specific objectives included types used and timing, motivations for use and benefits received, sources of information on CAM and communication with doctors. Semi-structured in-depth interviews were conducted with 19 patients and survivors (mean age = 57 years). Findings on frequency and type of CAM use were consistent with previous studies. Additionally, we found that the main expected benefit from using CAM was to boost the immune system, that participants could not readily explain the nature of the benefits they received, that CAM practitioners and books were the main sources of CAM information, and that the majority reported some discussion of CAM with a doctor. A greater range of questions needs to be asked of cancer patients in future quantitative studies. Reasons for commencing and stopping use of CAM and the quality of the CAM information source will be imperative to uncover, especially as the Internet is increasing in importance as a source for health information.

Entities:  

Mesh:

Year:  2006        PMID: 16968318     DOI: 10.1111/j.1365-2354.2006.00667.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  23 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  The ethics of complementary therapy research recruitment: a case study.

Authors:  Fiona Barlow; George Lewith
Journal:  Br J Gen Pract       Date:  2009-04       Impact factor: 5.386

3.  Health-related behavior change after cancer: results of the American cancer society's studies of cancer survivors (SCS).

Authors:  Nikki A Hawkins; Tenbroeck Smith; Luhua Zhao; Juan Rodriguez; Zahava Berkowitz; Kevin D Stein
Journal:  J Cancer Surviv       Date:  2009-11-10       Impact factor: 4.442

4.  Has the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007?

Authors:  Catherine A Okoro; Guixiang Zhao; Chaoyang Li; Lina S Balluz
Journal:  J Altern Complement Med       Date:  2012-10-16       Impact factor: 2.579

5.  Nurse and patient characteristics predict communication about complementary and alternative medicine.

Authors:  Christine N Spencer; Gabriel Lopez; Lorenzo Cohen; Diana L Urbauer; D Michael Hallman; Michael J Fisch; Patricia A Parker
Journal:  Cancer       Date:  2016-03-17       Impact factor: 6.860

6.  The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education.

Authors:  Peter J Smith; Alexandra M Clavarino; Jeremy E Long; Kathryn J Steadman
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

7.  Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway.

Authors:  Silje Engdal; Aslak Steinsbekk; Olbjørn Klepp; Odd Georg Nilsen
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

Review 8.  Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.

Authors:  Rishma Walji; Heather Boon; Emma Guns; Doreen Oneschuk; Jawaid Younus
Journal:  Support Care Cancer       Date:  2007-06-30       Impact factor: 3.603

9.  Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey.

Authors:  Yuen-chi Lam; Chung-wah Cheng; Heng Peng; Chun-key Law; Xianzhang Huang; Zhaoxiang Bian
Journal:  Chin Med       Date:  2009-12-30       Impact factor: 5.455

10.  Complementary and alternative medicine use by glioma patients in Switzerland.

Authors:  Günter Eisele; Ulrich Roelcke; Katrin Conen; Fabienne Huber; Tobias Weiss; Silvia Hofer; Oliver Heese; Manfred Westphal; Caroline Hertler; Patrick Roth; Michael Weller
Journal:  Neurooncol Pract       Date:  2018-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.